Correction to: Studies on H2-Assisted Liquefied Petroleum Gas Reduction of NO over Ag/Al2O3 Catalyst

Correction to: Bulletin of Chemical Reaction Engineering & Catalysis (2018), 13 (2): 227-235 (doi:10.9767/bcrec.13.2.1307.227-235)An error appeared in Corresponding Author in a paper entitled “Studies on H2-Assisted Liquefied Petroleum Gas Reduction of NO over Ag/Al2O3 Catalyst” published in Bulletin of Chemical Reaction Engineering & Catalysis. The Corresponding Author is corrected to be:* Corresponding Authors. Tel: +919415268192. Email: [email protected] (R. Prasad) Tel: +917505072607. Email: [email protected] (D. Yadav)——————The original article can be found online at: https://doi.org/10.9767/bcrec.13.2.1307.227-235——————Copyright © 2020 by Authors, Published by BCREC Group. This is an open access article under the CC BY-SA License (https://creativecommons.org/licenses/by-sa/4.0).How to Cite: Singh, P., Yadav, D., Thakur, P., Pandey, J., Prasad, R. (2020). Correction to: Studies on H2-Assisted Liquefied Petroleum Gas Reduction of NO over Ag/Al2O3 Catalyst. Bulletin of Chemical Reaction Engineering & Catalysis, 15 (2): 603-603 (doi:10.9767/bcrec.15.2.7659.603-603)Permalink/DOI: https://doi.org/10.9767/bcrec.15.2.7659.603-60

Studies on H2-Assisted Liquefied Petroleum Gas Reduction of NO over Ag/Al2O3 Catalyst

Hydrocarbon-Selective catalytic reduction (HC-SCR) is one of the potential methods to remove NOx emissions from diesel engine, lean burn petrol engines and natural gas engines exhaust. Ag/Al2O3 is a good catalyst for HC-SCR of NOx under lean-burn conditions. Further, addition of small amount of H2 is effective for enhancing HC-SCR activity. This effect is unique to silver and to specific Ag/support combinations, namely, Ag/γ-Al2O3. Various HC reductants, such as: octane, decane, dodecane and propane, have been reported in the literatures. Only a single study on LPG as a reductant over Cu-ZSM catalyst was reported. There was no work reported on H2 assisted LPG over Ag/Al2O3 catalyst. Thus, this gap in the literature is filled with the present investigation of NO reduction over 2 wt.% Ag/Al2O3 catalyst using LPG reductant. The fresh and used catalyst was characterized by various techniques like low temperature N2-adsorption, XRD, XPS and SEM. There was practically no change in the characteristics of the fresh and used catalyst. Two different reductants of CO and LPG were compared for SCR of NO over the catalyst without and with H2-assisted. The experiments were performed in a fixed bed tubular flow reactor under the following conditions: 100mg catalyst; 0.13% NO, 2.5% LPG/CO, 1% H2, 10% O2, rest Ar; total flow rate 60 mL/min; temperature ambient 400 oC and pressure 1 atm. Around 100% conversion of NO was achieved using LPG reductant. Light off temperature of NO reduction significantly reduced by H2assisted LPG reductant. The maximum conversion of NO with CO was limited to 35.15% at temperature of 224 oC and above. Whereas, 97.79 % NO conversion was achieved at 365 oC with LPG reductant. While, the maximum conversions with H2-LPG and H2-CO reductants were 100 and 99.46% at 117 and 220 oC, respectively. Therefore, H2-LPG-SCR of NOx over 2 wt.% Ag/Al2O3 catalyst system can be used to get 100% reduction at low temperature.

Role of Nephrostomy in poorly functioning kidneys in patients with ureteropelvic junction obstruction (UPJO)

Introduction: Several studies have addressed the unique management challenges in poorly functioning kidneys of patients with ureteropelvic junction obstruction. Trial with percutaneous drainage of such kidneys as a guide to choose the type of surgical management would be a solution to this dilemma. We aimed to evaluate the role of percutaneous nephrostomy in treatment of poorly functioning kidneys in pediatric patients with UPJO.Materials and Methods: A prospective study was performed on patients with poorly functioning kidneys (split renal function<10% on renal dynamic scan) and unilateral ureteropelvic junction obstruction from August 2016 to January 2018. Ultrasound-guided nephrostomy was inserted for these patients. Data regarding the differential renal function and glomerular function rate (GFR) was collected before and after nephrostomy insertion. Decision regarding pyeloplasty or nephrectomy of the involved kidney was made based on changes seen in differential function and Glomerular filtration rate following the drainage.Results: Thirty three patients with unilateral UPJO with poorly functioning kidneys were treated during this period. Thirty patients had significant increase in differential function and glomerular filtration rate. These patients underwent pyeloplasty. In 2 patients, these parameters did not increase much and they underwent nephrectomy. One patient had an infected kidney which did not improve significantly on drainage and had to be removed. Of the 30 patients who had pyeloplasty, two developed obstruction after 3 months of removal of double-J stent and needed reoperation.Conclusion: Percutaneous nephrostomy in poorly functioning kidneys with ureteropelvic junction obstruction helps to identify potentially salvageable kidneys which merit pyeloplasty. Kidneys which do not improve with nephrostomy are unlikely to improve with pyeloplasty and therefore nephrectomy is done in such cases.

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

SummaryBackground The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden of disease. By providing national and subnational assessments spanning the past 25 years, this study can inform debates on the importance of addressing risks in context. Methods We used the comparative risk assessment framework developed for previous iterations of the Global Burden of Disease Study to estimate attributable deaths, disability-adjusted life-years (DALYs), and trends in exposure by age group, sex, year, and geography for 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks from 1990 to 2015. This study included 388 risk-outcome pairs that met World Cancer Research Fund-defined criteria for convincing or probable evidence. We extracted relative risk and exposure estimates from randomised controlled trials, cohorts, pooled cohorts, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. We developed a metric that allows comparisons of exposure across risk factors—the summary exposure value. Using the counterfactual scenario of theoretical minimum risk level, we estimated the portion of deaths and DALYs that could be attributed to a given risk. We decomposed trends in attributable burden into contributions from population growth, population age structure, risk exposure, and risk-deleted cause-specific DALY rates. We characterised risk exposure in relation to a Socio-demographic Index (SDI). Findings Between 1990 and 2015, global exposure to unsafe sanitation, household air pollution, childhood underweight, childhood stunting, and smoking each decreased by more than 25%. Global exposure for several occupational risks, high body-mass index (BMI), and drug use increased by more than 25% over the same period. All risks jointly evaluated in 2015 accounted for 57·8% (95% CI 56·6–58·8) of global deaths and 41·2% (39·8–42·8) of DALYs. In 2015, the ten largest contributors to global DALYs among Level 3 risks were high systolic blood pressure (211·8 million [192·7 million to 231·1 million] global DALYs), smoking (148·6 million [134·2 million to 163·1 million]), high fasting plasma glucose (143·1 million [125·1 million to 163·5 million]), high BMI (120·1 million [83·8 million to 158·4 million]), childhood undernutrition (113·3 million [103·9 million to 123·4 million]), ambient particulate matter (103·1 million [90·8 million to 115·1 million]), high total cholesterol (88·7 million [74·6 million to 105·7 million]), household air pollution (85·6 million [66·7 million to 106·1 million]), alcohol use (85·0 million [77·2 million to 93·0 million]), and diets high in sodium (83·0 million [49·3 million to 127·5 million]). From 1990 to 2015, attributable DALYs declined for micronutrient deficiencies, childhood undernutrition, unsafe sanitation and water, and household air pollution; reductions in risk-deleted DALY rates rather than reductions in exposure drove these declines. Rising exposure contributed to notable increases in attributable DALYs from high BMI, high fasting plasma glucose, occupational carcinogens, and drug use. Environmental risks and childhood undernutrition declined steadily with SDI; low physical activity, high BMI, and high fasting plasma glucose increased with SDI. In 119 countries, metabolic risks, such as high BMI and fasting plasma glucose, contributed the most attributable DALYs in 2015. Regionally, smoking still ranked among the leading five risk factors for attributable DALYs in 109 countries; childhood underweight and unsafe sex remained primary drivers of early death and disability in much of sub-Saharan Africa. Interpretation Declines in some key environmental risks have contributed to declines in critical infectious diseases. Some risks appear to be invariant to SDI. Increasing risks, including high BMI, high fasting plasma glucose, drug use, and some occupational exposures, contribute to rising burden from some conditions, but also provide opportunities for intervention. Some highly preventable risks, such as smoking, remain major causes of attributable DALYs, even as exposure is declining. Public policy makers need to pay attention to the risks that are increasingly major contributors to global burden. Funding Bill & Melinda Gates Foundation

Genomic Approaches to Enhance Stress Tolerance for Productivity Improvements in Pearl Millet

Pearl millet [Pennisetum glaucum (L.) R. Br.], the sixth most important cereal crop (after rice, wheat, maize, barley, and sorghum), is grown as a grain and stover crop by the small holder farmers in the harshest cropping environments of the arid and semiarid tropical regions of sub-Saharan Africa and South Asia. Millet is grown on ~31 million hectares globally with India in South Asia; Nigeria, Niger, Burkina Faso, and Mali in western and central Africa; and Sudan, Uganda, and Tanzania in Eastern Africa as the major producers. Pearl millet provides food and nutritional security to more than 500 million of the world’s poorest and most nutritionally insecure people. Global pearl millet production has increased over the past 15 years, primarily due to availability of improved genetics and adoption of hybrids in India and expanding area under pearl millet production in West Africa. Pearl millet production is challenged by various biotic and abiotic stresses resulting in a significant reduction in yields. The genomics research in pearl millet lagged behind because of multiple reasons in the past. However, in the recent past, several efforts were initiated in genomic research resulting into a generation of large amounts of genomic resources and information including recently published sequence of the reference genome and re-sequencing of almost 1000 lines representing the global diversity. This chapter reviews the advances made in generating the genetic and genomics resources in pearl millet and their interventions in improving the stress tolerance to improve the productivity of this very important climate-smart nutri-cereal

Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

BACKGROUND: Healthy life expectancy (HALE) and disability-adjusted life-years (DALYs) provide summary measures of health across geographies and time that can inform assessments of epidemiological p ..